GATA3 and Parkinson disease: GATA3 blood levels were depleted in PD patients who experienced sleep disturbances, suggesting that GATA3 could be potentially utilized as a novel non-invasive biomarker for early detection of PD, as well as predicting individuals who are at risk of developing non-motor symptoms.